Creation of monoclonal antibodies

Preliminary phase

  • Determination of very accurate specifications with the customer to identify the most appropriate strategy among all the techniques / protocols available.
  • Preparation and validation of the immunogen according to its nature and its immunogenic properties (coupling of hapten carrier, fragmentation, etc.).

MAB’Solut can produce and purify the proteinaceous target from its sequence or from a cDNA plasmid, and also synthesize a dedicated peptide for a peptide immunization strategy.

Immunization / Fusion / Screening

Deliverables_custom_antibodies3_copie

 

TOP